Role of mesenchymal stem cells in delivering Newcastle disease virus to glioma cells and glioma stem cells and enhancing the oncolytic effect of the virus by secreting TRAIL.
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3100)Outcome of an advanced anaplastic astrocytoma patient treated with Newcastle disease viral (NDV) oncolytic therapy.
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2013-05-31 / J Clin Oncol 31, 2013 (suppl; abstr e13029)The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-03-01 / Oncoimmunology 2013 Mar;2(3):e23401Vaccine strategies for glioblastoma: progress and future directions
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / Immunotherapy 2013 Feb;5(2):155-67Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / J. Immunother. 2013 Feb;36(2):152-7α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-12-27 / BMC Cancer 2012 Dec;12:623Immunotherapy with tumor vaccines for the treatment of malignant gliomas
/in Glioblastoma, International Publications /von 2012-12-01 / Curr Drug Discov Technol 2012 Dec;9(4):237-55Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2546)The final report of a phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with glioblastoma.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2084)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution